BioSpace News Archive

Follow along as BioSpace tracks job cuts and restructuring initiatives.

As AI-enabled Software as Medical Devices become more prevalent, regulatory agencies are responding with new guidelines and AI-specific authorisation routes. This article looks at current trends, suggests clinical considerations for medical device developers and anticipates AI-enabled SaMDs’ future progress.

Despite ranking among the world’s top scientific producers, Italy has struggled to turn research into startups. Now, stronger tech transfer offices, private capital and returning scientists are pushing the country toward a more mature innovation economy.

Virtual patients move AI beyond early discovery—toward the clinical decisions where drug-development value is won or lost